Aquestive Therapeutics
AQST
#7659
Rank
NZ$0.79 B
Marketcap
NZ$6.32
Share price
-6.61%
Change (1 day)
-37.91%
Change (1 year)

Earnings for Aquestive Therapeutics (AQST)

Earnings in 2026 (TTM): -NZ$0.12 Billion

According to Aquestive Therapeutics 's latest financial reports the company's current earnings are NZ$48.83 Million. In 2025 the company made an earning of -NZ$0.13 Billion a decrease over its 2024 earnings that were of -NZ$49.97 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aquestive Therapeutics from 2017 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.12 Billion-7.73%
2025 -NZ$0.13 Billion143.96%
2024 -NZ$49.97 Million16669.33%
2023 -NZ$0.3 Million-99.61%
2022 -NZ$76.72 Million-12.56%
2021 -NZ$87.74 Million12.24%
2020 -NZ$78.17 Million-24.89%
2019 -NZ$0.11 Billion6.04%
2018 -NZ$98.14 Million4243.61%
2017 -NZ$2.26 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-NZ$0.3 Billion 147.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-NZ$33.19 Million-71.78%๐Ÿ‡บ๐Ÿ‡ธ USA